Disease and disorder research has been conducted in relation to the Cell Projection Organization Pathway and Encephalitis, Urticaria, Hiv Infections, Neurodegenerative Disorders, Inflammation. The study of the Cell Projection Organization Pathway has been mentioned in research publications which can be found using our bioinformatics tool below. The Cell Projection Organization Pathway has been researched in relation to Regulation Of Biological Process, Cell Proliferation, Cell Migration, Developmental Process, Cell Development. The Cell Projection Organization Pathway complements our catalog of research reagents including antibodies and ELISA kits against BST2, BTF3P11, CTSD, DGKG, GAS1.
Top Research Reagents
We have 931 products for the study of the Cell Projection Organization Pathway that can be applied to Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.
![Western Blot: VEZF1 Antibody [NBP1-80115] - Human Fetal Muscle, Antibody Dilution: 1.0 ug/ml.](https://images.novusbio.com/fullsize/VEZF1-Antibody-Western-Blot-NBP1-80115-img0010.jpg)
![Immunohistochemistry: VEZF1 Antibody [NBP1-80115] - Staining of human brain. Antibody Concentration: 5 ug/ml.](https://images.novusbio.com/fullsize/VEZF1-Antibody-Immunohistochemistry-NBP1-80115-img0004.jpg)
![Immunohistochemistry-Paraffin: PDCD4 Antibody [NBP1-83302] - Staining in human breast and skeletal muscle tissues . Corresponding PDCD4 RNA-seq data are presented for the same tissues.](https://images.novusbio.com/fullsize/PDCD4-Antibody-Immunohistochemistry-Paraffin-NBP1-83302-img0021.jpg)
![Western Blot: PDCD4 Antibody [NBP1-83302] - Western blot analysis in mouse cell line NIH-3T3, rat cell line NBT-II and rat cell line pC12.](https://images.novusbio.com/fullsize/PDCD4-Antibody-Western-Blot-NBP1-83302-img0009.jpg)
![Immunocytochemistry/Immunofluorescence: BST2 Antibody (120G8.04) [DDX0390P-100] - Murine peyer patch: BST-2](https://images.novusbio.com/fullsize/BST2-Antibody-120G8-04-Immunocytochemistry-Immunofluorescence-DDX0390P-100-img0005.jpg)
![Immunohistochemistry: BST2 Antibody (120G8.04) [DDX0390P-100] - IHC staining of murine spleen cryosections](https://images.novusbio.com/fullsize/BST2-Antibody-120G8-04-Immunohistochemistry-DDX0390P-100-img0006.jpg)
![N/A Osteoprotegerin/TNFRSF11B [Biotin]](https://images.novusbio.com/fullsize2/DATA_Osteoprotegerin_DY805_ELISA_2238.jpg)
![Western Blot: Craniofacial Development Protein 1 Antibody (11811) [NBP2-43772] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with CFDP1 antibody [11811].](https://images.novusbio.com/fullsize/Craniofacial-Development-Protein-1-Antibody-11811-Western-Blot-NBP2-43772-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: Craniofacial Development Protein 1 Antibody (11811) [NBP2-43772] - Craniofacial Development Protein 1 Antibody (11811) detects Craniofacial Development Protein 1 protein at nucleus by immunofluorescent analysis. Sample: HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: Craniofacial Development Protein 1 stained by Craniofacial Development Protein 1 Antibody (11811) diluted at 1:100. Red: alpha Tubulin 4a, a cytoskeleton marker, stained by alpha Tubulin 4a antibody diluted at 1:500. Scale bar= 10 um.](https://images.novusbio.com/fullsize/Craniofacial-Development-Protein-1-Antibody-11811-Immunocytochemistry-Immunofluorescence-NBP2-43772-img0006.jpg)
